In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Cellectis S.A.. Trade Record

NASDAQ:CLLS Cellectis S.A. stock gains 7.48% Exit Apr 24, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart CLLS Apr 1, 2019, priceSeries
About Cellectis S.A.

Developing cancer immunotherapies based on gene-edited CAR T-cells.

Trade Information
Trade Type
LONG
ReliabilityScore™
88.89
Entry Date
Apr 1, 2019
Entry Price
18.57
Sell Date
Apr 24, 2019
Sell Price
19.96
Net Gain
7.48%
Hold Time
16 Trading Days